Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Gains from Investment Securities (2020 - 2025)

Immatics (IMTX) posted Gains from Investment Securities of -$150550.6 for Q2 2025, up 91.04% sequentially from -$1.7 million in Q1 2025, and down 121.57% YoY from $697823.1 in Q2 2024.

Analysis

Immatics (IMTX) Gains from Investment Securities (2020 - 2025) Analysis & Trends

Immatics has reported Gains from Investment Securities for 6 years, with the latest figure at -$150550.6 in Q2 2025.

  • Quarterly Gains from Investment Securities fell 121.57% year-over-year to -$150550.6 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$1.8 million (up 90.15% YoY) and the FY2025 annual result came in at -$2.0 million, up 89.54% from the prior year.
  • Gains from Investment Securities advanced to -$150550.6 in Q2 2025 per IMTX's latest filing, from -$1.7 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $14.3 million in Q2 2023 and troughed at -$18.5 million in Q1 2022.
  • A 5-year average of -$1.1 million and a median of $273636.3 in 2024 frame the typical range for Gains from Investment Securities.
  • The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities slumped 1365.71% in 2022, then surged 380.2% in 2023.
  • Over 5 years, Gains from Investment Securities stood at $1.8 million in 2021, then tumbled by 270.8% to -$3.1 million in 2022, then slumped by 144.09% to -$7.6 million in 2023, then tumbled by 82.33% to -$13.9 million in 2024, then surged by 98.92% to -$150550.6 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered -$150550.6, -$1.7 million, and -$13.9 million for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immatics 1.17 Bn 711.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -150,550.64
Mar 31, 2025 -1.68 Mn
Dec 31, 2024 -13.93 Mn
Sep 30, 2024 -4.21 Mn
Jun 30, 2024 697,823.15
Mar 31, 2024 -1.13 Mn
Dec 31, 2023 -5.41 Mn
Sep 30, 2023 1.52 Mn
Jun 30, 2023 14.27 Mn
Mar 31, 2023 -7.94 Mn
Dec 31, 2022 -3.13 Mn
Sep 30, 2022 5.91 Mn
Jun 30, 2022 2.97 Mn
Mar 31, 2022 -18.55 Mn
Dec 31, 2021 1.83 Mn
Sep 30, 2021 6.43 Mn
Jun 30, 2021 3.28 Mn
Mar 31, 2021 1.47 Mn
Dec 31, 2020 -5.51 Mn